Gene · 54890
Papers4,144
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 4,144
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of RNA modifications in the pathological mechanisms and therapeutic targeting of multiple myeloma. | Mol Cell Probes | 2026 | 42177998 | PubTator, text mining | PubMed |
| Long-read transcriptomic profiling of a glioma cell line following m6A regulator perturbations. | Biochem Biophys Rep | 2026 | 42170385 | PubTator, text mining | PubMed |
| m6A RNA methylation in sepsis-induced cardiomyopathy: direct cardiac mechanisms, emerging therapeutic targets, and translational gaps. | Front Med (Lausanne) | 2026 | 42158135 | PubTator, text mining | PubMed |
| Context-dependent functions of ALKBH5: a mechanistic framework linking cellular stress responses, immune regulation, viral infection, and therapeutic vulnerabilities. | Front Immunol | 2026 | 42148061 | PubTator, text mining | PubMed |
| m6A-Mediated epitranscriptomic control of mitochondrial dysfunction in neurodegeneration. | Mitochondrion | 2026 | 42140375 | PubTator, text mining | PubMed |
| Correction to "Tendon Organoids Enable Functional Tendon Rejuvenation Through ALKBH5-Dependent RNA Demethylation". | Adv Sci (Weinh) | 2026 | 42132925 | PubTator, text mining | PubMed |
| RNA methylation in kidney disorders: Insights into molecular machinery and therapeutic opportunities. | Cell Signal | 2026 | 42114790 | PubTator, text mining | PubMed |
| RNA methylation in cardiovascular remodeling: Molecular mechanisms, biomarkers, and therapeutic strategies. | Mol Biol Rep | 2026 | 42084676 | PubTator, text mining | PubMed |
| The N6-Methyladenosine RNA Demethylase AlkB Homolog 5 (ALKBH5) in Metabolic Diseases: Molecular Mechanisms and Pharmacological Implications-A Review. | Biomolecules | 2026 | 42072621 | PubTator, text mining | PubMed |
| ALKBH5 regulates key lipid metabolites to promote osteoporosis. | Medicine (Baltimore) | 2026 | 42071797 | PubTator, text mining | PubMed |
| Nitric oxide generates a coordinated histone modification signature consistent with chromatin compaction, linked to methyl-modifying enzyme dysregulation and tumor-permissive gene silencing. | Redox Biol | 2026 | 42019316 | PubTator, text mining | PubMed |
| m6A RNA methylation regulatory gene expression in response to ethanol and acetaldehyde exposure and withdrawal. | Environ Epigenet | 2026 | 41970606 | PubTator, text mining | PubMed |
| Correction to "ALKBH5-Mediated m6A Modification of lncRNA KCNQ1OT1 Triggers the Development of LSCC via Upregulation of HOXA9". | J Cell Mol Med | 2026 | 41964365 | PubTator, text mining | PubMed |
| ALKBH1 activity in vitro and human cell lines by isotope dilution mass spectrometry. | PLoS One | 2026 | 41941523 | PubTator, text mining | PubMed |
| Tamoxifen differentially modulates endometrial hyperplasia via wild-type and mutant p53 regulation of the ALKBH5-REG1A axis. | Front Oncol | 2026 | 41939469 | PubTator, text mining | PubMed |
| HucMSC-sEV-derived miR-320d alleviates IBD by inhibiting macrophage ferroptosis through m6A-mediated BCAT2 upregulation. | Bioorg Chem | 2026 | 41926795 | PubTator, text mining | PubMed |
| ALKBH5/IGF2BP1-mediated m6A demethylation of TRIM37 promotes pancreatic cancer tumorigenesis and glycolysis by mediating RBMX degradation. | Cell Biol Toxicol | 2026 | 41922631 | PubTator, text mining | PubMed |
| Medulloblastoma in Adolescents and Young Adults: Molecular Subgroups, Prognostic Biomarkers, and Age-Specific Therapeutic Challenges. | Curr Issues Mol Biol | 2026 | 41899451 | PubTator, text mining | PubMed |
| Ferroptosis in Glioblastoma and Neuroblastoma: Molecular Mechanisms and Novel Therapeutic Strategies. | Curr Issues Mol Biol | 2026 | 41899419 | PubTator, text mining | PubMed |
| Identification of Novel Alternative Transcripts of the Human ALKBH Gene Family and Investigation of Their Unique Expression Signatures in Cancer Cells. | Curr Issues Mol Biol | 2026 | 41899403 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54890/papers?page=4